Emergence agitation after laparoscopic sleeve gastrectomy

Dexmedetomidine infusion for analgesia and prevention of emergence agitation in morbid obese patients undergoing laparoscopic gastric sleeve gastrectomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201601001408927

Enrollment

Registered

2016-01-04

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Interventions

Group C

Group D

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -60 morbid obese patients (body mass index from 35-45 kg/m2) -American Society of Anesthesiologist (ASA) physical status: II and III -age: between 20-50 years -sex: both sexes. -operation:elective laparoscopic sleeve gastrectomy under general anesthesia.

Exclusion criteria

Exclusion criteria: - history of hypertension (controlled or uncontrolled) - cerebrovascular disease - cardiac disease - respiratory disease - hepatic disease - renal diseases - thyrotoxicosis - allergy to the study drugs. - therapy with vasoactive medications. - positive pregnancy test. - allergy to eggs or soy. - Patients who experienced major complications that may have contributed to a prolonged hospital stay or increased pain (intestinal leak or bleeding for example) were also excluded.

Design outcomes

Primary

Measure	Time frame
The incidence of emergence agitation and the postoperative pain.	—

Secondary

Measure	Time frame
The secondary outcome measures were postoperative hemodynamics, postoperative rescue analgesics and postoperative nausea and vomiting.	—

Countries

Egypt

Contacts

Public Contactmostafa mansour

lecturer of anesthesia and intensive care

mostafa_mansour361@hotmail.com00201093322145

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026